Acute Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies
University of Sao Paulo
40 participants
Oct 1, 2018
INTERVENTIONAL
Conditions
Summary
Systemic autoimmune myopathies are a heterogeneous group of rheumatic diseases that primarily affect the skeletal muscles. The transcranial direct current stimulation technique has been frequent, for example, in patients with ischemic stroke or for the optimization of muscular performance in athletes. However, to date, there are no studies evaluating this technique in patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, double-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of acute transcranial current stimulation session in patients with systemic autoimmune myopathies.
Eligibility
Inclusion Criteria3
- Classification criteria - EULAR/ACR 2017
- Classification critera - Connors et al.
- Objective muscle limb weakness
Exclusion Criteria6
- Neoplasia
- Using heart pacemarker
- Using visceral metalic clips
- Infections (HIV, HTLV-1, Hepatitis, etc)
- Pregnance
- Previous historical of convulsions or epilepsies
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients with systemic autoimmune myopathies will receive or not acute transcranial direct current stimulation session.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03749538